About this Research Topic
We aim to promote the application of BNCT with recent research results related to new neutron sources or new boron drugs or new indications, and related trials combined with BNCT and other treatment techniques are also favored. We welcome submissions covering but are not limited to the followings:
1) The effect of accelerator-based BNCT (AB-BNCT) on cancer treatment
2) Tumor pathology with reactor-based or accelerator-based BNCT
3) New drugs as boron carriers for BNCT in cancer treatment (in vivo studies)
4) Novel strategies for combining BNCT with other anti-cancer modalities
5) New findings related to BNCT clinical research
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Topic editor Dr. Hanna Koivunoro is employed by Neutron Therapeutics Finland (and declares no competing interests with regards to the Research Topic Subject). All other Topic Editors declare no competing interests with regards to the Research Topic subject.
Keywords: Boron neutron capture therapy, Malignant brain tumors, Head and neck cancers, L-boronophenylalanine, Accelerators
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.